论文部分内容阅读
本文报道隐原性纤维性肺泡炎(CFA)治疗前后 BALF 中磷脂成分的变化及与临床病情的关系。未经治疗的 CFA(均经病理证实)患者32例,对照组17例均无呼吸道疾病,年龄、性别及吸烟史与CFA 组相似。对照组和 CFA 治疗前均行右肺下叶外侧段 BAL,其回收液作8种磷脂成分分析,其后病人用强地松治疗(60mg/d,连续4周,后减量维持,不少于20mg qod,连用12周),治疗至少3个月后,再
This article reports the changes of phospholipid content in BALF before and after treatment of cryptogenic fibroblastic alveolitis (CFA) and its relationship with clinical conditions. 32 cases of untreated CFA (pathologically confirmed) patients, 17 cases of the control group have no respiratory disease, age, gender and smoking history and CFA group similar. Control group and CFA before treatment of right lower lobe of the lateral segment of BAL, the recovery of liquid for eight kinds of phospholipid composition analysis, followed by patients treated with prednisone (60mg / d, for 4 weeks after the reduction of maintenance, a lot of In 20mg qod, once every 12 weeks), after treatment for at least 3 months, and then